Cervical cancer has emerged as the fastest-growing cancer in Canada, posing a significant public health challenge that demands immediate attention from the federal government. This urgent call to action was articulated by the Society of Gynecologic Oncology of Canada during a press conference held in Ottawa. Despite the federal government’s action plan, introduced in July 2025, aiming to eradicate cervical cancer as a public health concern by 2040, experts argue that much more needs to be done to tackle this escalating crisis.
The Alarming Statistics
Dr. Shannon Salvador, president of the Society, highlighted the gravity of the situation, noting that in 2025, an estimated 1,650 Canadians were diagnosed with cervical cancer, with 430 expected to succumb to the disease—numbers that represent avoidable tragedies. “Canada is currently facing a silent national health crisis,” Dr. Salvador stated emphatically, stressing that while advancements in medical technology are noteworthy, they are overshadowed by persistent challenges in cervical cancer prevention and treatment.
The reliance on traditional Pap testing has proved inadequate, particularly as the rate of Human Papillomavirus (HPV) vaccinations remains disappointingly low. Currently, only 64% of eligible individuals in Canada have completed the HPV vaccination series, a figure far below the necessary threshold for effective elimination. “This statistic is not merely a medical failure; it is a policy failure,” Dr. Salvador declared.
A Call for Change
In response to these concerning trends, the Society of Gynecologic Oncology of Canada is advocating for decisive reforms. They propose a shift towards HPV DNA testing for cervical cancer screening and the introduction of self-collection kits that would allow individuals to collect samples in the comfort of their homes. This initiative is particularly vital for those facing barriers such as geographical isolation, historical trauma, and cultural marginalisation, which disproportionately affect rural, Indigenous, and underserved communities.
Dr. Sarah Kean, the provincial lead for cervical cancer in Manitoba, underscored the disparities in outcomes, particularly among Indigenous women, who often face higher rates of diagnosis and more advanced stages of the disease. “This is not due to biology,” she asserted, “but rather a reflection of systemic barriers, lack of access to resources, and the enduring impacts of colonial practices.”
The Economic Burden
The financial implications of cervical cancer are also staggering. Dr. Salvador pointed out that the costs associated with treating the disease were projected to reach approximately £132 million in 2024. In contrast, implementing comprehensive screening for eligible Canadians over five years would only cost around £106 million. The stark difference in these figures raises questions about the prioritisation of health policies and funding allocations.
The Global Context
The situation in Canada mirrors a troubling global trend. Following the World Health Organization’s (WHO) initiative five years ago to eliminate cervical cancer, the Canadian Cancer Society (CCS) has reported stagnation in the country’s progress. Recent data indicates that cervical cancer ranks as the fourth most commonly diagnosed cancer and the fourth leading cause of cancer-related deaths among women worldwide. Projections for 2024 suggest that about 1,600 women in Canada will be diagnosed with the condition, with 400 expected to die.
Dr. Kean emphasised that both Canada and the WHO have committed to the elimination of cervical cancer through three key pillars: vaccination, HPV-based DNA screening, and access to treatment. “It is alarming that while all other cancers are seeing a decline in incidence, cervical cancer—one that is entirely preventable—continues to rise,” she stated.
Why it Matters
The rising incidence of cervical cancer in Canada represents a profound public health failing that is entirely preventable. For many, access to life-saving vaccines and screening remains inadequate, particularly among vulnerable populations. As the Canadian healthcare system grapples with these disparities, it is imperative that policymakers heed the warnings of health advocates and implement meaningful changes. The health and lives of thousands depend on immediate action to enhance access to prevention and treatment resources, ensuring that cervical cancer no longer remains a silent crisis in our nation.
